Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Silo Pharma Inc SILO

Silo Pharma, Inc. is a developmental stage biopharmaceutical company. The Company is focused on developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It is engaged in acquiring and/or developing intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the potential benefits they may have in certain cases involving depression, mental health issues and neurological disorders. The Company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. Its SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Its two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS).


NDAQ:SILO - Post by User

Post by ProfPennyPinchon Apr 23, 2021 1:22pm
111 Views
Post# 33055906

Silo Wellness, keeping a close eye on this one

Silo Wellness, keeping a close eye on this one
 
Added a new one to my watchlist - $SILO (Silo Wellness). They are a producer of psychedelics and psilocybin nasal spray which also has a deal with the family of Bob Marley to have exclusive rights to create a Bob Marley brand of psychedelics. Additionally, the company runs retreats in Jamaica (recently announced 5 new “psychedelic wellness” retreats that will take place with the last one ending July 31).
 
https://www.globenewswire.com/news-release/2021/04/21/2213993/0/en/Silo-Wellness-Announces-Five-New-Psychedelic-Wellness-Retreats-in-Jamaica.html
 
Seeing strong support levels at $0.17 and with a current market cap of $12.5M they still have a lot of room to grow here. Just from the news flow this year I can see a lot of growth and preparations for the future. 
 
The psychedelic industry has had a lot of noise this year. New research studies, big IPOs, and inquiries into government legalization have all contributed to the term “shroom boom.” I’m expecting big things for the next few years and I’ll be watching $SILO closely.
 
<< Previous
Bullboard Posts
Next >>